- Home
- GMED vs SF Comparison
GMED vs SF Comparison
Compare GMED & SF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- SF
- Stock Information
- Founded
- GMED 2003
- SF 1890
- Country
- GMED United States
- SF United States
- Employees
- GMED N/A
- SF N/A
- Industry
- GMED Medical/Dental Instruments
- SF Investment Bankers/Brokers/Service
- Sector
- GMED Health Care
- SF Finance
- Exchange
- GMED Nasdaq
- SF Nasdaq
- Market Cap
- GMED 11.2B
- SF 9.0B
- IPO Year
- GMED 2012
- SF N/A
- Fundamental
- Price
- GMED $81.11
- SF $114.40
- Analyst Decision
- GMED Buy
- SF Hold
- Analyst Count
- GMED 14
- SF 7
- Target Price
- GMED $86.15
- SF $103.17
- AVG Volume (30 Days)
- GMED 1.0M
- SF 655.7K
- Earning Date
- GMED 11-05-2024
- SF 10-23-2024
- Dividend Yield
- GMED N/A
- SF 1.47%
- EPS Growth
- GMED N/A
- SF 27.32
- EPS
- GMED 0.67
- SF 5.54
- Revenue
- GMED $2,478,596,000.00
- SF $4,736,245,000.00
- Revenue This Year
- GMED $62.26
- SF $16.81
- Revenue Next Year
- GMED $6.76
- SF $9.32
- P/E Ratio
- GMED $120.85
- SF $20.67
- Revenue Growth
- GMED 102.10
- SF 10.26
- 52 Week Low
- GMED $44.02
- SF $60.17
- 52 Week High
- GMED $84.87
- SF $118.12
- Technical
- Relative Strength Index (RSI)
- GMED 64.46
- SF 66.86
- Support Level
- GMED $79.94
- SF $100.74
- Resistance Level
- GMED $83.74
- SF $118.12
- Average True Range (ATR)
- GMED 1.85
- SF 2.49
- MACD
- GMED 0.38
- SF 0.42
- Stochastic Oscillator
- GMED 67.47
- SF 78.60
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
About SF Stifel Financial Corporation
Stifel Financial is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 60% of the company's net revenue is derived from its global wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial-services firms.